• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Peregrine Pharmaceuticals - Articles and news items

Bavituximab and durvalumab combo to be evaluated in solid tumours

Industry news / 24 August 2015 / Victoria White

AstraZeneca and Peregrine Pharmaceuticals are to evaluate the safety and efficacy of Peregrine’s bavituximab in combination with AstraZeneca’s durvalumab…

 

Webinar: Understanding ISO Standards: ISO 14644-2:2015 Cleanroom MonitoringFIND OUT MORE
+ +